In a recent issue of the “Handbook of Clinical Neurology,” a chapter is devoted to the four atypical parkinsonism disorders — dementia with Lewy bodies (DLB), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD). The authors — both movement disorder specialists at the University of Florida — indicate that “diagnosis is critical as the atypical parkinsonisms herald symptom profiles and prognoses distinct” from Parkinson’s Disease (PD). They also indicate it’s important to identify the suspected underlying pathology — whether it be alpha-synuclein (for DLB and MSA) or tau (for PSP and CBD).
The authors give a brief overview of treatment for these disorders. Plus there's a table about "red flags" suggesting an atypical parkinsonism disorder.
Earlier this week, Brain Support Network posted a summary of the treatment section along with the table about "red flags." See:
brainsupportnetwork.org/red...
RobinR